How to classify biotech news
1. By Source Type
- Press release (corporate communication) – company announcements about trials, partnerships, funding.
- Original reporting (journalism) – investigative articles, analyst commentary, interviews.
- Scientific publication – peer-reviewed journal papers, preprints.
- Regulatory update – FDA/EMA approvals, guidance changes.
2. By Stage of Development
- Discovery & preclinical research – basic science, early lab studies, animal models.
- Clinical trials
- Phase I – safety
- Phase II – efficacy
- Phase III – pivotal/confirmatory
- Phase IV – post-marketing studies
- Regulatory milestones – IND/CTA filings, orphan drug designation, approvals.
- Commercial stage – launches, sales reports, manufacturing scale-up.
3. By Scientific/Technological Focus
- Therapeutic modality –
- Small molecules
- Biologics (antibodies, proteins)
- Cell therapy
- Gene therapy
- RNA therapeutics (mRNA, siRNA, ASO)
- Platform/technology –
- CRISPR/gene editing
- AI/ML in drug discovery
- Microbiome therapies
- Synthetic biology
- Biomaterials & drug delivery systems
4. By Disease Area
- Oncology (immunotherapy, targeted therapy)
- Rare diseases (orphan indications)
- Neurology (Alzheimer’s, Parkinson’s)
- Infectious diseases (vaccines, antivirals)
- Metabolic & cardiovascular diseases
- Regenerative medicine
5. By Business/Market Impact
- Financing news – IPOs, venture funding, M&A.
- Partnerships & licensing – pharma-biotech collaborations.
- Market outlook – pricing, reimbursement, health economics.
- Manufacturing & supply chain – new facilities, CDMO partnerships.
6. Practical Classification Framework
When you encounter a biotech news article, you can tag it across three dimensions:
- Source type (Press release, Journalism, Regulatory, Science)
- Content type (Clinical trial, Technology, Business, Regulation)
- Domain focus (Therapeutic area, Modality, Market)
For example:
- “Moderna announces positive Phase III mRNA vaccine results” → Press release | Clinical trial | Infectious disease, RNA therapy
- “FDA approves CRISPR-based therapy for sickle cell disease” → Regulatory update | Approval | Gene editing, Rare disease
by ChatGPT
